Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis

Published:2016-02-24 Issue:5 Volume:118 Page:731-741
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Boyle Peter¹²,Koechlin Alice¹²,Bota Maria¹²,d'Onofrio Alberto²,Zaridze David G.³,Perrin Paul⁴,Fitzpatrick John⁵,Burnett Arthur L.⁶,Boniol Mathieu¹²

Affiliation:

1. Strathclyde Institute of Global Public Health at iPRI; Ecully Lyon Ouest France

2. International Prevention Research Institute; Lyon France

3. Institute of Carcinogenesis; Moscow Russia

4. Urologie; Centre Hospitalier Lyon Sud; Pierre-Bénite France

5. Irish Cancer Society; Dublin Ireland

6. Department of Urology, Cellular and Molecular Medicine; Johns Hopkins Medicine; Marburg Baltimore MD USA

Funder

Repros Therapeutics Inc

International Prevention Research Institute

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13417/fullpdf

Reference78 articles.

1. Baltimore Longitudinal Study of A. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging;Harman;J Clin Endocrinol Metab,2001

2. Prevalence of symptomatic androgen deficiency in men;Araujo;J Clin Endocrinol Metab,2007

3. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study;Wu;J Clin Endocrinol Metab,2008

4. Testosterone Deficiency Syndrome (TDS) needs to be named appropriately-the importance of accurate terminology;Morales;Eur Urol,2006

5. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations;Wang;Eur Urol,2009

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EMAS position statement: Testosterone replacement therapy in older men;Maturitas;2023-12

2. Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men;Acta Oncologica;2023-11-16

3. Effect of statins and testosterone replacement therapy on incident cardiovascular disease among male hormone-related cancer survivors;2023-11-03

4. Risk of Urological Cancer Among Boys and Men Born with Hypospadias: A Swedish Population-based Study;European Urology Open Science;2023-11

5. Does testosterone replacement therapy increase the risk of conversion to treatment in patients with prostate cancer on active surveillance?;Urologic Oncology: Seminars and Original Investigations;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3